454 Finds Virus Clue to Disappearing Bee Disorder



In important research published this week, 454 Life Sciences (Roche) says its technology has provided a critical clue into the perplexing mystery of the decimated bee populations in North America.

honeybeeThe so-called colony collapse disorder (CCD) has mystified biologists for over a year, with an estimated 10 billion bees (2.4 million hives) lost. First recognized last year in the Unites States, similar outbreaks have since been reported across continental Europe. A host of theories have been put forward to explain the disappearance, but no convincing clues. In August, the New Yorker published a superb article by Elizabeth Kolbert on the search for the mystery CCD agent.

454 and scientists at Columbia University led by Diana Cox-Foster and Ian Lipkin undertook a “metagenomic” approach to identify possible culprits. The results, reported this week in Science, revealed traces of several foreign viruses, fungi, and bacteria associated with the honeybee affected populations. However, one sequence appears particularly significant: that of the Israeli Acute paralysis Paralysis Virus (IAPV), which was only detected in the collapsed colonies.

The authors of the study stress that this does not prove a causal relationship between IAPV and CCD. “Nonetheless, the prevalence of IAPV sequences in CCD operations, as well as the temporal and geographic overlap of CCD and importation of IAPV infected bees, indicate that IAPV is a significant marker for CCD,” the authors conclude.

“Unbiased 454 sequencing technology enabled us to rapidly assemble a comprehensive inventory of microflora in [CCD] and non-CCD populations, and provided the sequence information needed to identify candidate pathogens,” said Lipkin. “We view this work as a model for investigating epidemics of unexplained infectious disease.”

“We are very pleased to see our technology applied to solve real-world problems. We are hopeful this latest research will help eliminate the threat of CCD to global agriculture,” commented Christopher McLeod, president of 454. McLeod touted the ability of 454’s approach to detect and identify various organisms without prior knowledge of the sample’s constituents.

Bees are essential for the pollination of more than 90 fruit and vegetable crops worldwide. In CCD, the worker bees mysteriously disappear from honeybee colonies. A prevailing theory is that the bees’ immune systems are somehow compromised, facilitating infection by a wide variety of organisms. The observation that irradiated honeycombs from affected colonies could be repopulated with healthy bees, while non-sterilized combs could not, suggested an infectious basis for CCD.

Further Reading:
Stung, by Elizabeth Kolbert. The New Yorker. August 6, 2007.

Cox-Foster, DL et al. “A metagenomic survey of microbes in honey bee colony collapse disorder," Science, September 7, 2007.

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1



White Papers & Special Reports

sgi - whp 1
Turning Genomics Data into Practical Insight
Sponsored by SGI

With worldwide sequencing capacity approaching 13 quadrillion DNA bases annually turning genomics data into knowledge is a true computational challenge. Read this paper and learn how the SGI UV coherent shared memory platform can:  

  • Speed results time while cost competitively tackling the most difficult computational problems across all omics disciplines. 
  • Push performance by scaling to extraordinary levels, up to 256 sockets (2,560 cores, 4,096 threads) per single system (one OS image). 

Provide support for up to 16TB of coherent shared memory in a single system image enabling extreme efficiency across a wide range of compute demands. 



accerlys-logo_2012_wh
New Complimentary Market Survey…
Collaborations and Communications Within Drug Discovery Research
Sponsored by Accelrys
This survey was conducted by the Cambridge Healthtech Media Group in January, 2012. It was sponsored by Accelrys related to their HEOS initiative to gather valid information around externalizing collaborative research while improving communications in the cloud. With 310 qualified industry respondents the survey findings reveal useful usage and trends patterns.  An insightful follow-on discussion and webinar related to this survey, and the HEOS by Scynexis SaaS portal is also available on the Bio-IT World website for complementary viewing.
 


Job Openings

tessella logo 
Scientific Software Engineer
Boston MA
$70,000 to $95,000
 

Tessella delivers software engineering and consulting services to leading pharmaceutical and biotech companies. We are recruiting Software Engineersto work with skilled bioinformaticians and scientists to identify business needs and recommend and develop technical solutions. Applicants require BS, MS or PhD in bioinformatics, biology or chemistry and 2+ years of software development in either: Java, C#, C++, C or VB.NET. 

Apply at http://jobs.tessella.com   

 

oxford nanopore logo 


 Early Access Collaborations Managers
Oxford Nanopore Technologies is developing a novel technology, GridIONTM for the direct, electronic analysis of DNA/RNA and other analytes.  As the system approaches the market, we are building a team of technically knowledgeable, highly motivated candidates with excellent customer service and facilitation skills to join our company as Collaboration Managers.  This is a unique opportunity to work with world-leading genomics customers throughout the early adoption phase of a new generation of DNA sequencing technology.. This is a facilitative, enabling role with responsibility for managing technology development collaborations with key customers at leading genomics institutions.  It will include long term management of the collaboration plan and milestones and associated meetings and documentation. Click here to find out more and apply   

Oxford Nanopore's GridION technology, VP, Sales and Marketing Oxford Nanopore Technologies is a fast-moving technology company that is developing a novel electronic molecular analysis technology. The technology is adaptable for the analysis of DNA/RNA, proteins, chemicals and other molecules.  It is therefore suitable for use in a variety of markets including scientific research and clinical applications.  As the technology approaches the market, Oxford Nanopore is seeking a visionary VP of sales and marketing to join the senior team.  The candidate will embrace the opportunities afforded by entering the market with a truly disruptive technology that has the potential to expand the number of users and the variety of applications in each target market.  This is a rare opportunity to influence the commercial strategy at an early phase of its commercial lifetime, in a well funded company.  Oxford Nanopore welcomes applications from candidates with a track record of high-level strategic commercial  leadership, who wish to apply a fresh approach to existing markets.  Experience in Life Sciences/DNA sequencing is central to this role, however we will consider your application if you have experience of disruptive technologies in other related industries.  We are particularly interested in candidates with strong expertise in the use of digital technologies for sales and marketing of scientific/technical products.  Click to  Apply  


 

For reprints and/or copyright permission, please contact  Tim McLucas, (781) 972-1342, tmclucas@healthtech.com .